Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04672863 · ClinicalTrials.gov registry record · NA

Mediterranean Diet Post-liver Transplantation

A NA study of Liver Transplantation, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04672863: Recruiting NA study of Liver Transplantation, sponsored by Mayo Clinic.

NCT04672863 is a NA study of Liver Transplantation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 317-participant average among 12 other Liver Transplantation trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04672863, a NA study of Liver Transplantation, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to study the effects of a structured Mediterranean dietary program on prevention of weight gain, promotion of heart health and prevention of fatty liver disease after liver transplantation.

Primary Outcome

weight in kilograms

Conditions Studied

Interventions

  • BEHAVIORAL Dietary Intervention

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-01-19
Est. Completion 2027-11
Phase NA
Mayo Clinic

2,844 total trials

What NCT04672863 shows while recruiting

NCT04672863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 317-participant average among 12 other Liver Transplantation trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Liver Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Dietary Intervention is the first listed.

NCT04672863 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04672863 about?

NCT04672863 is a clinical study titled "Mediterranean Diet Post-liver Transplantation". The purpose of this study is to study the effects of a structured Mediterranean dietary program on prevention of weight gain, promotion of heart health and prevention of fatty liver disease after liver transplantation.

What is the current status of trial NCT04672863?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-01-19. Estimated completion is 2027-11.

What conditions does trial NCT04672863 study?

This clinical trial studies the following conditions: Liver Transplantation.

What interventions are being tested in trial NCT04672863?

The interventions under investigation include: Dietary Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04672863?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04672863 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04672863's enrollment target sits among peer trials

80 8th of 12 higher than 5 of 12 other Liver Transplantation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Liver Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04672863, the US trial registry maintained by the National Library of Medicine. NCT04672863 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.